Skip to main content
Vijay Nambi, MD, Cardiology, Houston, TX

VijayNambiMD

Cardiology • Houston, TX

Adult Congenital Heart Disease

Associate Professor, Medicine, Baylor College of Medicine

Join to view full profile

Dr. Nambi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Nambi's full profile

Already have an account?

  • Office

    1504 Taub Loop
    Houston, TX 77030
    Phone+1 713-873-2000
    Fax+1 713-798-1144

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Cardiovascular Disease, 2003 - 2006
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Internal Medicine, 1999 - 2002
  • University of Illinois College of Medicine at Chicago
    University of Illinois College of Medicine at ChicagoInternship, Internal Medicine, 1998 - 1999
  • Madras Medical College
    Madras Medical CollegeClass of 1998

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2005 - 2025
  • OH State Medical License
    OH State Medical License 2000 - 2003
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Associations Between Carotid Artery Plaque Burden, Plaque Characteristics, and Cardiovascular Events  
    Salim S Virani, Vijay Nambi, Christie M Ballantyne, JAMA Cardiology
  • Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index  
    Rohan Khera, Vijay Nambi, Stephen L Seliger, Monika M Safford, Robert J Mentz, Donald M Lloyd-Jones, Ian J Neeland, JAMA Network Open
  • Original Investigation Remnant-like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease  
    Christie M Ballantyne, Anum Saeed, Vijay Nambi, Salim S Virani, Cameron S Guild, ScienceDirect

Lectures

  • Safety of Evolocumab in People Living with HIV Infection an Important First Step 
    American Heart Association, Scientific Sessions 2011, Orlando, Florida, USA
  • Safety of Evolocumab in People Living with HIV Infection an Important First Step 
    Scientific Sessions 2011, Orlando, Florida, USA
  • So You Know Your Lipids! Let's Ask Some Questions and Discuss Some Cases 
    2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019

Authored Content

  • Safety of Evolocumab in People Living with HIV Infection an Important First StepMay 2020

Press Mentions

  • Uptick in Natriuretic Peptides with Long-Term Serial Testing Predicts New Heart Failure
    Uptick in Natriuretic Peptides with Long-Term Serial Testing Predicts New Heart FailureFebruary 14th, 2023
  • Uptake Uncertain for Potent New LDL-Lowerer Inclisiran
    Uptake Uncertain for Potent New LDL-Lowerer InclisiranJanuary 26th, 2022
  • As COVID-19 Drags on, the Cardiology Fallout May Haunt for Years
    As COVID-19 Drags on, the Cardiology Fallout May Haunt for YearsDecember 16th, 2021
  • Join now to see all

Grant Support

  • Improving Cardiovascular Risk Assessment Using Ultrasound ImagingNational Heart, Lung, And Blood Institute2009–2011

Dr. Vijay Nambi, Dr. Vijay Nambi, MD, Dr. V Nambi